WHO selects CAMO to monitor pharmaceutical quality
OSLO – September 24th 2018 – CAMO Analytics, the leader in industrial analytics, today announced that WHO Essential Medicines and Health Products has chosen CAMO to provide a solution for monitoring and verifying the quality of pharmaceutical products and identifying manufactured products not meeting the required quality standards. The WHO Essential Medicines and Health Products Department works with countries to promote affordable access to quality, safe and effective medicines, vaccines, diagnostics and other medical devices. The first phase of the project will leverage CAMO’s expertise in building robust models, validated to the highest pharmaceutical standards. The next phases will be to deploy the developed solution across the global WHO network and to ensure patient safety and product quality is maintained at a high standard across the world, including low-resourced health systems.